All the news Showing 10 of 13 articles from: Drug-drug interactionsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources How to Check Drug Interactions With Hep C Medications Filter / 07 January 2020 How Well Do Docs Manage Potential Conflicts Between Hep C and HIV Meds? Manual Items / 10 April 2018 Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals Liz Highleyman / 13 March 2017 AbbVie's investigational glecaprevir/pibrentasvir treatment for hepatitis C is not expected to interact with or require dose adjustment when taken with commonly used antiretroviral regimens, offering a new option for people with HIV/hepatitis C ... Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study Liz Highleyman / 21 July 2016 The once-daily co-formulation of sofosbuvir and velpatasvir was highly effective against all hepatitis C virus (HCV) genotypes in people with HIV/HCV co-infection and was safe and well tolerated in the ASTRAL-5 trial, according ... Understanding the Role of Statins in the DAA Era Healio / 25 April 2016 New hepatitis C treatments cause adverse effects in the elderly Medscape (requires free registration) / 21 March 2016 Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals Liz Highleyman / 11 March 2016 Sofosbuvir/velpatasvir, a forthcoming combination that effectively treats all hepatitis C virus (HCV) genotypes, can be safely used with most boosted antiretrovirals for people with HIV and HCV co-infection, according to a study presented ... Many patients on new HCV medications at risk of drug-drug interactions Medscape (requires free registration) / 23 December 2015 Impact of Food and Antacids on Levels of Ledipasvir and Sofosbuvir NATAP / 28 May 2014 New HCV protease inhibitors interact with a wide range of drugs used in treatment of psychiatric conditions Michael Carter / 28 June 2013 Recently licensed direct-acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) infection do not pose a significant risk of psychiatric side-effects but have several important interactions with drugs used to treat ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive